Prostate cancer: health watchdog reverses NHS guidance on drug – The Guardian

A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said. Abiraterone, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months. The National Institute for Health …

Posted in Uncategorized